[1] | Goodier JL, Kazazian HH Jr. Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell, 2008, 135(1): 23-35. | [2] | Liu Q, Wang JH, Li XY, Cen S. The connection between LINE-1 retrotransposition and human tumorigenesis. Hereditas (Beijing), 2016, 38(2): 93-102. | [2] | 刘茜, 王瑾晖, 李晓宇, 岑山. 逆转录转座子LINE-1与肿瘤的发生和发展. 遗传, 2016, 38(2): 93-102. | [3] | Dewannieux M, Esnault C, Heidmann T. LINE-mediated retrotransposition of marked Alu sequences. Nat Genet, 2003, 35(1): 41-48. | [4] | Ostertag EM, Goodier JL, Zhang Y, Kazazian HH Jr. SVA elements are nonautonomous retrotransposons that cause disease in humans. Am J Hum Genet, 2003, 73(6): 1444-1451. | [5] | Branciforte D, Martin SL. Developmental and cell type specificity of LINE-1 expression in mouse testis: implications for transposition. Mol Cell Biol, 1994, 14(4): 2584-2592. | [6] | Kano H, Godoy I, Courtney C, Vetter MR, Gerton GL, Ostertag EM, Kazazian HH Jr. L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism. Genes Dev, 2009, 23(11): 1303-1312. | [7] | Garcia-Perez JL, Marchetto MCN, Muotri AR, Coufal NG, Gage FH, O'Shea KS, Moran JV. LINE-1 retrotransposition in human embryonic stem cells. Hum Mol Genet, 2007, 16(13): 1569-1577. | [8] | Van den Hurk JAJM, Meij IC, del Carmen Seleme M, Kano H, Nikopoulos K, Hoefsloot LH, Sistermans EA, de Wijs IJ, Mukhopadhyay A, Plomp AS, de Jong PTVM, Kazazian HH, Cremers FPM. L1 retrotransposition can occur early in human embryonic development. Hum Mol Genet, 2007, 16(13): 1587-1592. | [9] | Giordano R, Magnano AR, Zaccagnini G, Pittoggi C, Moscufo N, Lorenzini R, Spadafora C. Reverse transcriptase activity in mature spermatozoa of mouse. J Cell Biol, 2000, 148(6): 1107-1113. | [10] | Vitullo P, Sciamanna I, Baiocchi M, Sinibaldi-Vallebona P, Spadafora C. LINE-1 retrotransposon copies are amplified during murine early embryo development. Mol Reprod Dev, 2012, 79(2): 118-127. | [11] | Pittoggi C, Sciamanna I, Mattei E, Beraldi R, Lobascio AM, Mai A, Quaglia MG, Lorenzini R, Spadafora C. Role of endogenous reverse transcriptase in murine early embryo development. Mol Reprod Dev, 2003, 66(3): 225-236. | [12] | Beraldi R, Pittoggi C, Sciamanna I, Mattei E, Spadafora C. Expression of LINE-1 retroposons is essential for murine preimplantation development. Mol Reprod Dev, 2006, 73(3): 279-287. | [13] | Sciamanna I, Vitullo P, Curatolo A, Spadafora C. A reverse transcriptase-dependent mechanism is essential for murine preimplantation development. Genes, 2011, 2(2): 360-373. | [14] | Mangiacasale R, Pittoggi C, Sciamanna I, Careddu A, Mattei E, Lorenzini R, Travaglini L, Landriscina M, Barone C, Nervi C, Lavia P, Spadafora C. Exposure of normal and transformed cells to nevirapine, a reverse transcriptase inhibitor, reduces cell growth and promotes differentiation. Oncogene, 2003, 22(18): 2750-2761. | [15] | Gualtieri A, Andreola F, Sciamanna I, Sinibaldi-Vallebona P, Serafino A, Spadafora C. Increased expression and copy number amplification of LINE-1 and SINE B1 retrotransposable elements in murine mammary carcinoma progression. Oncotarget, 2013, 4(11): 1882-1893. | [16] | Patnala R, Lee SH, Dahlstrom JE, Ohms S, Chen L, Dheen ST, Rangasamy D. Inhibition of LINE-1 retrotransposon- encoded reverse transcriptase modulates the expression of cell differentiation genes in breast cancer cells. Breast Cancer Res Treat, 2014, 143(2): 239-253. | [17] | Chen L, Dahlstrom JE, Chandra A, Board P, Rangasamy D. Prognostic value of LINE-1 retrotransposon expression and its subcellular localization in breast cancer. Breast Cancer Res Treat, 2012, 136(1): 129-142. | [18] | Rodi? N, Sharma R, Sharma R, Zampella J, Dai LX, Taylor MS, Hruban RH, Iacobuzio-Donahue CA, Maitra A, Torbenson MS, Goggins M, Shih I M, Duffield AS, Montgomery EA, Gabrielson E, Netto GJ, Lotan TL, De Marzo AM, Westra W, Binder ZA, Orr BA, Gallia GL, Eberhart CG, Boeke JD, Harris CR, Burns KH. Long interspersed element-1 protein expression is a hallmark of many human cancers. Am J Pathol, 2014, 184(5): 1280-1286. | [19] | Hancks DC, Kazazian HH Jr. Active human retrotransposons: variation and disease. Curr Opin Genet Dev, 2012, 22(3): 191-203. | [20] | Kaer K, Speek M. Retroelements in human disease. Gene, 2013, 518(2): 231-241. | [21] | Rodi? N, Burns KH. Long interspersed element-1 (LINE- 1): passenger or driver in human neoplasms?. PLoS Genet, 2013, 9(3): e1003402. | [22] | Landriscina M, Fabiano A, Altamura S, Bagala C, Piscazzi A, Cassano A, Spadafora C, Giorgino F, Barone C, Cignarelli M. Reverse transcriptase inhibitors down-regulate cell proliferation in vitro and in vivo and restore thyrotropin signaling and iodine uptake in human thyroid anaplastic carcinoma. J Clin Endocrinol Metab, 2005, 90(10): 5663-5671. | [23] | Sciamanna I, Landriscina M, Pittoggi C, Quirino M, Mearelli C, Beraldi R, Mattei E, Serafino A, Cassano A, Sinibaldi-Vallebona P, Garaci E, Barone C, Spadafora C. Inhibition of endogenous reverse transcriptase antagonizes human tumor growth. Oncogene, 2005, 24(24): 3923-3931. | [24] | Sciamanna I, Gualtieri A, Cossetti C, Osimo EF, Ferracin M, Macchia G, Aricò E, Prosseda G, Vitullo P, Misteli T, Spadafora C. A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines. Oncotarget, 2013, 4(12): 2271-2287. | [25] | Oricchio E, Sciamanna I, Beraldi R, Tolstonog GV, Schumann GG, Spadafora C. Distinct roles for LINE-1 and HERV-K retroelements in cell proliferation, differentiation and tumor progression. Oncogene, 2007, 26(29): 4226-4233. | [26] | Damm K, Hemmann U, Garin-Chesa P, Hauel N, Kauffmann I, Priepke H, Niestroj C, Daiber C, Enenkel B, Guilliard B, Lauritsch I, Müller E, Pascolo E, Sauter G, Pantic M, Martens UM, Wenz C, Lingner J, Kraut N, Rettig WJ, Schnapp A. A highly selective telomerase inhibitor limiting human cancer cell proliferation. EMBO J, 2001, 20(24): 6958-6968. | [27] | Aschacher T, Wolf B, Enzmann F, Kienzl P, Messner B, Sampl S, Svoboda M, Mechtcheriakova D, Holzmann K, Bergmann M. LINE-1 induces hTERT and ensures telomere maintenance in tumour cell lines. Oncogene, 2016, 35(1): 94-104. | [28] | Morse B, Rotherg PG, South VJ, Spandorfer JM, Astrin SM. Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma. Nature, 1988, 333(6168): 87-90. | [29] | Miki Y, Nishisho I, Horii A, Miyoshi Y, Utsunomiya J, Kinzler KW, Vogelstein B, Nakamura Y. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res, 1992, 52(3): 643-645. | [30] | Iskow RC, McCabe MT, Mills RE, Torene S, Pittard WS, Neuwald AF, Van Meir EG, Vertino PM, Devine SE. Natural mutagenesis of human genomes by endogenous retrotransposons. Cell, 2010, 141(7): 1253-1261. | [31] | Lee E, Iskow R, Yang LX, Gokcumen O, Haseley P, Luquette LJ III, Lohr JG, Harris CC, Ding L, Wilson RK, Wheeler DA, Gibbs RA, Kucherlapati R, Lee C, Kharchenko PV, Park PJ, The Cancer Genome Atlas Research Network. Landscape of somatic retrotransposition in human cancers. Science, 2012, 337(6097): 967-971. | [32] | Solyom S, Ewing AD, Rahrmann EP, Doucet T, Nelson HH, Burns MB, Harris RS, Sigmon DF, Casella A, Erlanger B, Wheelan S, Upton KR, Shukla R, Faulkner GJ, Largaespada DA, Kazazian HH Jr. Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res, 2012, 22(12): 2328-2338. | [33] | Shukla R, Upton KR, Mu?oz-Lopez M, Gerhardt DJ, Fisher ME, Nguyen T, Brennan PM, Baillie JK, Collino A, Ghisletti S, Sinha S, Iannelli F, Radaelli E, Dos Santos A, Rapoud D, Guettier C, Samuel D, Natoli G, Carninci P, Ciccarelli FD, Garcia-Perez JL, Faivre J, Faulkner GJ. Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell, 2013, 153(1): 101-111. | [34] | Doucet-O'Hare TT, Rodi? N, Sharma R, Darbari I, Abril G, Choi JA, Ahn JY, Cheng YL, Anders RA, Burns KH, Meltzer SJ, Kazazian HH Jr. LINE-1 expression and retrotransposition in Barrett's esophagus and esophageal carcinoma. Proc Natl Acad Sci USA, 2015, 112(35): E4894-E4900. | [35] | Rodi? N, Steranka JP, Makohon-Moore A, Moyer A, Shen PL, Sharma R, Kohutek ZA, Huang CR, Ahn D, Mita P, Taylor MS, Barker NJ, Hruban RH, Iacobuzio-Donahue CA, Boeke JD, Burns KH. Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinoma. Nat Med, 2015, 21(9): 1060-1064. | [36] | Kandoth C, McLellan MD, Vandin F, Ye K, Niu BF, Lu C, Xie MC, Zhang QY, McMichael JF, Wyczalkowski MA, Leiserson MDM, Miller CA, Welch JS, Walter MJ, Wendl MC, Ley TJ, Wilson RK, Raphael BJ, Ding L. Mutational landscape and significance across 12 major cancer types. Nature, 2013, 502(7471): 333-339. | [37] | Nagy R, Sweet K, Eng C. Highly penetrant hereditary cancer syndromes. Oncogene, 2004, 23(38): 6445-6470. | [38] | Callinan PA, Batzer MA. Retrotransposable elements and human disease. Genome Dyn, 2006, 1: 104-115. | [39] | The ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature, 2012, 489(7414): 57-74. | [40] | Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F, Xue C H, Marinov GK, Khatun J, Williams BA, Zaleski C, Rozowsky J, R?der M, Kokocinski F, Abdelhamid RF, Alioto T, Antoshechkin I, Baer MT, Bar NS, Batut P, Bell K, Bell I, Chakrabortty S, Chen X, Chrast J, Curado J, Derrien T, Drenkow J, Dumais E, Dumais J, Duttagupta R, Falconnet E, Fastuca M, Fejes-Toth K, Ferreira P, Foissac S, Fullwood MJ, Gao H, Gonzalez D, Gordon A, Gunawardena H, Howald C, Jha S, Johnson R, Kapranov P, King B, Kingswood C, Luo OJ, Park E, Persaud K, Preall JB, Ribeca P, Risk B, Robyr D, Sammeth M, Schaffer L, See LH, Shahab A, Skancke J, Suzuki AM, Takahashi H, Tilgner H, Trout D, Walters N, Wang HE, Wrobel J, Yu YB, Ruan XA, Hayashizaki Y, Harrow J, Gerstein M, Hubbard T, Reymond A, Antonarakis SE, Hannon G, Giddings MC, Ruan YJ, Wold B, Carninci P, Guigó R, Gingeras TR. Landscape of transcription in human cells. Nature, 2012, 489(7414): 101-108. | [41] | Piatek MJ, Werner A. Endogenous siRNAs: regulators of internal affairs. Biochem Soc Trans, 2014, 42(4): 1174-1179. | [42] | Kim VN, Han JJ, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol, 2009, 10(2): 126-139. | [43] | Pelechano V, Steinmetz LM. Gene regulation by antisense transcription. Nat Rev Genet, 2013, 14(12): 880-893. | [44] | Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet, 2014, 15(1): 7-21. | [45] | Aalto AP, Pasquinelli AE. Small non-coding RNAs mount a silent revolution in gene expression. Curr Opin Cell Biol, 2012, 24(3): 333-340. | [46] | Li LC. Chromatin remodeling by the small RNA machinery in mammalian cells. Epigenetics, 2014, 9(1): 45-52. | [47] | Borchert GM, Holton NW, Williams JD, Hernan WL, Bishop IP, Dembosky JA, Elste JE, Gregoire NS, Kim JA, Koehler WW, Lengerich JC, Medema AA, Nguyen MA, Ower GD, Rarick MA, Strong BN, Tardi NJ, Tasker NM, Wozniak DJ, Gatto C, Larson ED. Comprehensive analysis of microRNA genomic loci identifies pervasive repetitive-element origins. Mob Genet Elements, 2011, 1(1): 8-17. | [48] | Watanabe T, Tomizawa SI, Mitsuya K, Totoki Y, Yamamoto Y, Kuramochi-Miyagawa S, Iida N, Hoki Y, Murphy PJ, Toyoda A, Gotoh K, Hiura H, Arima T, Fujiyama A, Sado T, Shibata T, Nakano T, Lin HF, Ichiyanagi K, Soloway PD, Sasaki H. Role for piRNAs and noncoding RNA in de novo DNA methylation of the imprinted mouse Rasgrf1 locus. Science, 2011, 332(6031): 848-852. | [49] | Kelley D, Rinn J. Transposable elements reveal a stem cell-specific class of long noncoding RNAs. Genome Biol, 2012, 13(11): R107. | [50] | Kapusta A, Kronenberg Z, Lynch VJ, Zhuo XY, Ramsay L, Bourque G, Yandell M, Feschotte C. Transposable elements are major contributors to the origin, diversification, and regulation of vertebrate long noncoding RNAs. PLoS Genet, 2013, 9(4): e1003470. | [51] | Yang N, Kazazian HH Jr. L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells. Nat Struct Mol Biol, 2006, 13(9): 763-771. | [52] | Malone CD, Hannon GJ. Small RNAs as guardians of the genome. Cell, 2009, 136(4): 656-668. | [53] | Slotkin RK, Martienssen R. Transposable elements and the epigenetic regulation of the genome. Nat Rev Genet, 2007, 8(4): 272-285. | [54] | B?hne A, Brunet F, Galiana-Arnoux D, Schultheis C, Volff JN. Transposable elements as drivers of genomic and biological diversity in vertebrates. Chromosome Res, 2008, 16(1): 203-215. | [55] | Bourque G. Transposable elements in gene regulation and in the evolution of vertebrate genomes. Curr Opin Genet Dev, 2009, 19(6): 607-612. | [56] | Esnault C, Maestre J, Heidmann T. Human LINE retrotransposons generate processed pseudogenes. Nat Genet, 2000, 24(4): 363-367. | [57] | Wei W, Gilbert N, Ooi SL, Lawler JF, Ostertag EM, Kazazian HH, Boeke JD, Moran JV. Human L1 retrotransposition: cis preference versus trans complementation. Mol Cell Biol, 2001, 21(4): 1429-1439. | [58] | Kulpa DA, Moran JV. Cis-preferential LINE-1 reverse transcriptase activity in ribonucleoprotein particles. Nat Struct Mol Biol, 2006, 13(7): 655-660. | [59] | Pink RC, Wicks K, Caley DP, Punch EK, Jacobs L, Carter DRF. Pseudogenes: pseudo-functional or key regulators in health and disease?. RNA, 2011, 17(5): 792-798. | [60] | Ullu E, Weiner AM. Human genes and pseudogenes for the 7SL RNA component of signal recognition particle. EMBO J, 1984, 3(13): 3303-3310. | [61] | Ka?ar Y, Thomann HU, Gross HJ. The first human genes for tRNA ArgICG, tRNA GlyUCC, and tRNA ThrIGU and more tRNA Val pseudogenes: expression and pre-tRNA maturation in HeLa cell-free extracts. DNA Cell Biol, 1992, 11(10): 781-790. | [62] | Doucet AJ, Droc G, Siol O, Audoux J, Gilbert N. U6 snRNA pseudogenes: Markers of retrotransposition dynamics in Mammals. Mol Biol Evol, 2015, 32(7): 1815-1832. | [63] | Perreault J, No?l JF, Brière F, Cousineau B, Lucier JF, Perreault JP, Boire G. Retropseudogenes derived from the human Ro/SS-A autoantigen-associated hY RNAs. Nucleic Acids Res, 2005, 33(6): 2032-2041. | [64] | Sciamanna I, Gualtieri A, Piazza PV, Spadafora C. Regulatory roles of LINE-1-encoded reverse transcriptase in cancer onset and progression. Oncotarget, 2014, 5(18): 8039-8051. | [65] | Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. MicroRNA expression profiles classify human cancers. Nature, 2005, 435(7043): 834-838. | [66] | Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen CF, Ambros VR, Israel MA. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res, 2007, 67(6): 2456-2468. | [67] | Jansson MD, Lund AH. MicroRNA and cancer. Mol Oncol, 2012, 6(6): 590-610. | [68] | Chen L, Dahlstrom JE, Lee SH, Rangasamy D. Naturally occurring endo-siRNA silences LINE-1 retrotransposons in human cells through DNA methylation. Epigenetics, 2012, 7(7): 758-771. | [69] | Ohms S, Lee SH, Rangasamy D. LINE-1 retrotransposons and let-7 miRNA: partners in the pathogenesis of cancer? Front Genet, 2014, 5: 338. | [70] | Spadafora C. Sperm-mediated 'reverse' gene transfer: a role of reverse transcriptase in the generation of new genetic information. Hum Reprod, 2008, 23(4): 735-740. | [71] | Suh N, Baehner L, Moltzahn F, Melton C, Shenoy A, Chen J, Blelloch R. MicroRNA function is globally suppressed in mouse oocytes and early embryos. Curr Biol, 2010, 20(3): 271-277. | [72] | Ma YL, Zhang P, Wang F, Yang JJ, Yang Z, Qin HL. The relationship between early embryo development and tumourigenesis. J Cell Mol Med, 2010, 14(12): 2697-2701. | [73] | Kaiser S, Park YK, Franklin JL, Halberg RB, Yu M, Jessen WJ, Freudenberg J, Chen XD, Haigis K, Jegga AG, Kong S, Sakthivel B, Xu H, Reichling T, Azhar M, Boivin GP, Roberts RB, Bissahoyo AC, Gonzales F, Bloom GC, Eschrich S, Carter SL, Aronow JE, Kleimeyer J, Kleimeyer M, Ramaswamy V, Settle SH, Boone B, Levy S, Graff JM, Doetschman T, Groden J, Dove WF, Threadgill DW, Yeatman TJ, Coffey RJ Jr, Aronow BJ. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol, 2007, 8(7): R131. | [74] | Spadafora C. A LINE-1-encoded reverse transcriptase-dependent regulatory mechanism is active in embryogenesis and tumorigenesis. Ann N Y Acad Sci, 2015, 1341(1): 164-171. | [75] | Hagan CR, Rudin CM. Mobile genetic element activation and genotoxic cancer therapy: potential clinical implications. Am J Pharmacogenomics, 2002, 2(1): 25-35. | [76] | Terasaki N, Goodier JL, Cheung LE, Wang YJ, Kajikawa M, Kazazian HH Jr, Okada N. In vitro screening for compounds that enhance human L1 mobilization. PLoS One, 2013, 8(9): e74629. | [77] | Meacham CE, Morrison SJ. Tumour heterogeneity and cancer cell plasticity. Nature, 2013, 501(7467): 328-337. | [78] | Sciamanna I, De Luca C, Spadafora C. The reverse transcriptase encoded by LINE-1 retrotransposons in the genesis, progression, and therapy of cancer. Front Chem, 2016, 4: 6. | [79] | Harris CR, Normart R, Yang QF, Stevenson E, Haffty BG, Ganesan S, Cordon-Cardo C, Levine AJ, Tang LH. Association of nuclear localization of a long interspersed nuclear element-1 protein in breast tumors with poor prognostic outcomes. Genes Cancer, 2010, 1(2): 115-124. | [80] | Su YH, Davies S, Davis M, Lu H, Giller R, Krailo M, Cai QY, Robison L, Shu XO. Expression of LINE-1 p40 protein in pediatric malignant germ cell tumors and its association with clinicopathological parameters: a report from the Children's Oncology Group. Cancer Lett, 2007, 247(2): 204-212. | [81] | Belancio VP, Roy-Engel AM, Pochampally RR, Deininger P. Somatic expression of LINE-1 elements in human tissues. Nucleic Acids Res, 2010, 38(12): 3909-3922. | [82] | Miousse IR, Koturbash I. The fine LINE: methylation drawing the cancer landscape. Biomed Res Int, 2015, 2015: 131547. | [83] | Hanahan D. Rethinking the war on cancer. Lancet, 2014, 383(9916): 558-563. | [84] | Houédé N, Pulido M, Mourey L, Joly F, Ferrero JM, Bellera C, Priou F, Lalet C, Laroche-Clary A, Raffin MC, Ichas F, Puech A, Piazza PV. A phase II trial evaluating the efficacy and safety of efavirenz in metastatic castration-resistant prostate cancer. Oncologist, 2014, 19(12): 1227-1228. |
|